CNTA

Centessa Pharmaceuticals plc - ADR

22.44

USD

CNTA Earnings Reports

Positive Surprise Ratio

CNTA beat 11 of 18 last estimates.

61%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.39

Implied change from Q3 25 (Revenue/ EPS)

-4.88%

Implied change from Q4 24 (Revenue/ EPS)

-31.58%

Centessa Pharmaceuticals plc - ADR earnings per share and revenue

On Nov 05, 2025, CNTA reported earnings of -0.41 USD per share (EPS) for Q3 25, missing the estimate of -0.39 USD, resulting in a -3.48% surprise. Revenue reached --, compared to an expected 918.00 thousand, with a -100.00% difference. The market reacted with a -5.14% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.39 USD, with revenue projected to reach -- USD, implying an decrease of -4.88% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Centessa Pharmaceuticals plc - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Centessa Pharmaceuticals plc - ADR reported EPS of -$0.41, missing estimates by -3.48%, and revenue of $0.00, -100% below expectations.

How did the market react to Centessa Pharmaceuticals plc - ADR's Q3 2025 earnings?

The stock price moved down -5.14%, changed from $23.74 before the earnings release to $22.52 the day after.

When is Centessa Pharmaceuticals plc - ADR expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Centessa Pharmaceuticals plc - ADR's next earnings report?

Based on 16 analysts, Centessa Pharmaceuticals plc - ADR is expected to report EPS of -$0.39 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.